As of 2025-11-22, the Relative Valuation of Pfizer Inc (PFE) is 32.41 USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.04 USD, the upside of Pfizer Inc based on Relative Valuation is 29.4%.
The range of the Relative Valuation is 23.22 - 46.88 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.5x - 27.1x | 22.8x |
| Forward P/E multiples | 17.6x - 19.9x | 19.3x |
| Fair Price | 23.22 - 46.88 | 32.41 |
| Upside | -7.3% - 87.2% | 29.4% |
| Date | P/E |
| 2025-11-21 | 14.48 |
| 2025-11-20 | 14.11 |
| 2025-11-19 | 14.39 |
| 2025-11-18 | 14.72 |
| 2025-11-17 | 14.51 |
| 2025-11-14 | 14.50 |
| 2025-11-13 | 14.92 |
| 2025-11-12 | 14.96 |
| 2025-11-11 | 14.76 |
| 2025-11-10 | 14.11 |
| 2025-11-07 | 14.13 |
| 2025-11-06 | 14.37 |
| 2025-11-05 | 14.24 |
| 2025-11-04 | 14.06 |
| 2025-11-03 | 14.26 |
| 2025-10-31 | 14.26 |
| 2025-10-30 | 14.05 |
| 2025-10-29 | 14.05 |
| 2025-10-28 | 14.17 |
| 2025-10-27 | 14.33 |
| 2025-10-24 | 14.32 |
| 2025-10-23 | 14.27 |
| 2025-10-22 | 14.30 |
| 2025-10-21 | 14.37 |
| 2025-10-20 | 14.28 |
| 2025-10-17 | 14.18 |
| 2025-10-16 | 14.02 |
| 2025-10-15 | 14.11 |
| 2025-10-14 | 14.18 |
| 2025-10-13 | 14.30 |
| 2025-10-10 | 14.33 |
| 2025-10-09 | 14.60 |
| 2025-10-08 | 14.85 |
| 2025-10-07 | 15.20 |
| 2025-10-06 | 15.29 |
| 2025-10-03 | 15.83 |
| 2025-10-02 | 15.66 |
| 2025-10-01 | 15.74 |
| 2025-09-30 | 14.74 |
| 2025-09-29 | 13.80 |
| 2025-09-26 | 13.74 |
| 2025-09-25 | 13.65 |
| 2025-09-24 | 13.93 |
| 2025-09-23 | 13.96 |
| 2025-09-22 | 13.91 |
| 2025-09-19 | 13.90 |
| 2025-09-18 | 13.97 |
| 2025-09-17 | 13.91 |
| 2025-09-16 | 13.82 |
| 2025-09-15 | 13.87 |